OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
NEO
NeoGenomics, Inc.
Common Stock
6.24
-0.48
-7.14%
Delayed (15 Min) Trade Data: 12:00am 07/18/2025
Business Description
NeoGenomics Laboratories is a specialized genetics laboratory providing the latest diagnostic testing technologies to the pathology and oncology Communities. Staffed with specially trained hematopathologists and cytogenetic professionals, NeoGenomics Laboratories offers testing in cancer genetics, flow cytometry, immunohistochemistry and molecular diagnostics through its network of regional laboratories.
Financial Reporting
Reporting Status
U.S. Reporting: SEC Reporting
Audited Financials
Audited
Latest Report
CIK
0001077183
Fiscal Year End
12/31
Company Officers & Contacts
Douglas M. VanOort
CEO
George Cardoza
CFO
Steven C. Jones
EVP, Fin.
Grant Carlson
VP, Business Development
Robert Horel
VP, Sales & Mktg.
Jerome J. Dvonch
Director, Fin.
Edwin F. Weidig III
Principal Acct. Officer, Director, Fin.
Board of Directors
Raymond R. Hipp
Other Company Insiders
Not available
Service Providers
Accounting/Auditing Firm
Kingery & Crouse, P.A.2801 West Busch Blvd
Suite 200
Tampa, FL 33618
Profile Data
SIC - Industry Classification
8734 - Testing laboratories
Incorporation Information
NV, US
Employees
Not Available
Shell
No
Products and Services
Not available
Company Facilities
Not available
Company Notes
Formerly=American Communications Enterprises, Inc. until 1-02
Loading...
Symbol
OTCM
Last
58.00
Change
0.50 (0.87%)
Bid
58.00
Ask
59.00
Volume
2093
Time
00:00
